(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | ---- | -33.66%63.52M | -26.24%40.34M | -37.34%95.75M | -5.20%54.69M | -68.58%152.81M | --57.69M | --486.29M | ---- | ---- |
Operating income | -33.66%63.52M | -26.24%40.34M | -37.34%95.75M | -5.20%54.69M | -68.58%152.81M | 57.69M | 486.29M | |||
Cost of sales | ---- | 27.43%-60.32M | 17.27%-37.93M | 40.63%-83.11M | 13.70%-45.85M | -217.30%-139.98M | ---53.13M | ---44.12M | ---- | ---- |
Operating expenses | 27.43%-60.32M | 17.27%-37.93M | 40.63%-83.11M | 13.70%-45.85M | -217.30%-139.98M | -53.13M | -44.12M | |||
Gross profit | -74.65%3.2M | -72.81%2.4M | -1.53%12.63M | 93.88%8.83M | -97.10%12.83M | 4.56M | 442.17M | |||
Administrative expenses | 10.65%-21.19M | -9.55%-46.62M | -4.11%-23.72M | 4.55%-42.55M | -22.94%-22.78M | 17.20%-44.58M | -49.73%-18.53M | 24.26%-53.84M | -80.64%-12.37M | -211.95%-71.08M |
Research and development expenses | 11.03%-176.83M | 16.45%-372.32M | -12.55%-198.75M | -58.68%-445.65M | -45.15%-176.59M | -51.03%-280.84M | -71.32%-121.66M | -33.80%-185.95M | -31.19%-71.01M | -63.72%-138.98M |
Special items of operating profit | -65.84%12.13M | -78.06%17.85M | -35.59%35.5M | 1,296.87%81.36M | 763.63%55.12M | 70.79%-6.8M | -286.69%-8.31M | -246.47%-23.27M | 26.75%4.45M | 154.60%15.89M |
Operating profit | -0.72%-185.89M | -0.93%-397.88M | -36.30%-184.56M | -23.43%-394.2M | 5.92%-135.41M | -278.32%-319.38M | -82.35%-143.94M | 192.24%179.11M | -37.36%-78.94M | -91.43%-194.17M |
Financing income | 0.08%22.07M | 91.27%47.07M | 185.85%22.05M | 31.15%24.61M | 0.93%7.72M | 496.85%18.77M | 317.48%7.64M | -41.04%3.14M | -38.72%1.83M | 1,095.52%5.33M |
Financing cost | -38.80%-5.23M | -266.17%-8.31M | -2,892.86%-3.77M | -299.65%-2.27M | 58.42%-126K | 62.06%-568K | 57.86%-303K | -8.95%-1.5M | -17.87%-719K | 32.75%-1.37M |
Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -619.18%-1.69B | -633.34%-733.08M | -345.34%-235.61M |
Earning before tax | -1.67%-169.05M | 3.43%-359.12M | -30.08%-166.28M | -23.47%-371.86M | 6.42%-127.83M | 80.10%-301.19M | 83.15%-136.6M | -255.48%-1.51B | -422.98%-810.9M | -173.07%-425.82M |
After-tax profit from continuing operations | -1.67%-169.05M | 3.43%-359.12M | -30.08%-166.28M | -23.47%-371.86M | 6.42%-127.83M | 80.10%-301.19M | 83.15%-136.6M | -255.48%-1.51B | -422.98%-810.9M | -173.07%-425.82M |
Earning after tax | -1.67%-169.05M | 3.43%-359.12M | -30.08%-166.28M | -23.47%-371.86M | 6.42%-127.83M | 80.10%-301.19M | 83.15%-136.6M | -255.48%-1.51B | -422.98%-810.9M | -173.07%-425.82M |
Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 97.81%-22K | 99.15%-8K | 85.04%-1.01M |
Profit attributable to shareholders | -1.67%-169.05M | 3.43%-359.12M | -30.08%-166.28M | -23.47%-371.86M | 6.42%-127.83M | 80.10%-301.19M | 83.15%-136.6M | -256.31%-1.51B | -426.16%-810.9M | -184.70%-424.81M |
Basic earnings per share | 0.00%-0.22 | 6.12%-0.46 | -29.41%-0.22 | -22.50%-0.49 | 5.56%-0.17 | 89.92%-0.4 | 92.56%-0.18 | -104.64%-3.97 | 31.25%-2.42 | 43.11%-1.94 |
Diluted earnings per share | 0.00%-0.22 | 6.12%-0.46 | -29.41%-0.22 | -22.50%-0.49 | 5.56%-0.17 | 89.92%-0.4 | 92.56%-0.18 | -104.64%-3.97 | 31.25%-2.42 | 43.11%-1.94 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data